249 related articles for article (PubMed ID: 29135581)
21. High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.
Katundu KGH; Mukhula V; Phiri T; Phiri C; Filisa-Kaphamtengo F; Chipewa P; Chirambo G; Mipando M; Mwandumba HC; Muula AS; Kumwenda J
BMC Cardiovasc Disord; 2022 Dec; 22(1):557. PubMed ID: 36544081
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.
Agu CE; Uchendu IK; Nsonwu AC; Okwuosa CN; Achukwu PU
BMC Public Health; 2019 Aug; 19(1):1143. PubMed ID: 31429736
[TBL] [Abstract][Full Text] [Related]
23. [Factors associated with the optimum simultaneous control of diabetes, arterial hypertension and hypercholesterolemia in the diabetic population. BPC Diabetes study].
Llisterri-Caro JL; Turégano-Yedro M; Cinza-Sanjurjo S; Segura-Fragoso A; Sánchez-Sánchez B; Cubelos-Fernández N; Velilla-Zancada S; Micó-Pérez RM; Martín-Sánchez V;
Semergen; 2022; 48(4):225-234. PubMed ID: 34479796
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of renal impairment in individuals seeking HIV testing in Urban Malawi.
Glaser N; Phiri S; Bruckner T; Nsona D; Tweya H; Ahrenshop N; Neuhann F
BMC Nephrol; 2016 Nov; 17(1):186. PubMed ID: 27875991
[TBL] [Abstract][Full Text] [Related]
25. Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study.
Chhoun P; Ngin C; Tuot S; Pal K; Steel M; Dionisio J; Pearson H; Mburu G; Brody C; Yi S
Int J Equity Health; 2017 Jul; 16(1):125. PubMed ID: 28705242
[TBL] [Abstract][Full Text] [Related]
26. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
[No Abstract] [Full Text] [Related]
27. Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study.
Appiah LT; Sarfo FS; Huffman MD; Nguah SB; Stiles JK
Clin Cardiol; 2019 Dec; 42(12):1195-1201. PubMed ID: 31571256
[TBL] [Abstract][Full Text] [Related]
28. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda.
Mateen FJ; Kanters S; Kalyesubula R; Mukasa B; Kawuma E; Kengne AP; Mills EJ
J Hypertens; 2013 Jul; 31(7):1372-8; discussion 1378. PubMed ID: 23615323
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of cardiovascular risk factors by HIV status in a population-based cohort in South Central Uganda: a cross-sectional survey.
Enriquez R; Ssekubugu R; Ndyanabo A; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekstrom AM; Sewankambo NK; Serwadda DM; Nordenstedt H
J Int AIDS Soc; 2022 Apr; 25(4):e25901. PubMed ID: 35419976
[TBL] [Abstract][Full Text] [Related]
30. Premature age-related comorbidities among HIV-infected persons compared with the general population.
Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
Rahman Al-Nuaim A
Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study.
Ahmed HA; Mohamed J; Akuku IG; Lee KK; Alam SR; Perel P; Shah J; Ali MK; Eskander S; Chung MH; Shah AS
BMJ Open; 2022 Jun; 12(6):e062352. PubMed ID: 35667720
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk factors among ART-experienced people with HIV in South Africa.
Hyle EP; Bekker LG; Martey EB; Huang M; Xu A; Parker RA; Walensky RP; Middelkoop K
J Int AIDS Soc; 2019 Apr; 22(4):e25274. PubMed ID: 30990252
[TBL] [Abstract][Full Text] [Related]
34. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies.
Calvo-Sánchez M; Perelló R; Pérez I; Mateo MG; Junyent M; Laguno M; Blanco JL; Martínez-Rebollar M; Sánchez M; Mallolas J; Gatell JM; Domingo P; Martínez E
HIV Med; 2013 Jan; 14(1):40-8. PubMed ID: 23088307
[TBL] [Abstract][Full Text] [Related]
35. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
Kim KI; Kim CH
Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).
Appiah LT; Sarfo FS; Nguah SB; Huffman MD; Stiles JK; Feinstein MJ
Glob Heart; 2020 Nov; 15(1):74. PubMed ID: 33299770
[TBL] [Abstract][Full Text] [Related]
37. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.
Bekolo CE; Nguena MB; Ewane L; Bekoule PS; Kollo B
BMC Public Health; 2014 Mar; 14():236. PubMed ID: 24606888
[TBL] [Abstract][Full Text] [Related]
38. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us.
Catalán-Ramos A; Verdú JM; Grau M; Iglesias-Rodal M; del Val García JL; Consola A; Comin E;
Aten Primaria; 2014 Jan; 46(1):15-24. PubMed ID: 24325864
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study.
Ekrikpo UE; Akpan EE; Ekott JU; Bello AK; Okpechi IG; Kengne AP
BMJ Open; 2018 Jul; 8(7):e019664. PubMed ID: 30030310
[TBL] [Abstract][Full Text] [Related]
40. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Baker JV; Sharma S; Achhra AC; Bernardino JI; Bogner JR; Duprez D; Emery S; Gazzard B; Gordin J; Grandits G; Phillips AN; Schwarze S; Soliman EZ; Spector SA; Tambussi G; Lundgren J;
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28533305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
